Management of patients with fibromyalgia using biofeedback: A randomized control trial

Babu, Abraham Samuel; Mathew, Elsa; Danda, Debashish; Prakash, Henry

doi:10.4103/0019-5359.33710

Cited by 34 publications

(28 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Biofeedback is one of the few mind-body interventions that can potentially be blinded through the use of sham feedback. 45,46 Thus, placebo or expectancy effects which have a significant impact in many disorders are especially difficult to control for in mind-body clinical trials. 47,48 The potential benefit of a treatment in which the patient actively participates may be due to increased self-efficacy, the person's sense of ability to deal with a situation which, by itself, is associated with physiologic benefits.…”

Section: Placebo Effectsmentioning

confidence: 99%

Mind–body interventions

Wahbeh

Elsas

Oken³

2008

Neurology

282

127

View full text Add to dashboard Cite

Objective-Half of the adults in the United States use complementary and alternative medicine with mind-body therapy being the most commonly used form. Neurology patients often turn to their physicians for insight into the effectiveness of the therapies and resources to integrate them into their care. The objective of this article is to give a clinical overview of mind-body interventions and their applications in neurology.Methods-Medline and PsychInfo were searched on mind-body therapies and neurologic disease search terms for clinical trials and reviews and published evidence was graded.Results-Meditation, relaxation, and breathing techniques, yoga, tai chi, and qigong, hypnosis, and biofeedback are described. Mind-body therapy application to general pain, back and neck pain, carpal tunnel syndrome, headaches, fibromyalgia, multiple sclerosis, epilepsy, muscular dysfunction, stroke, aging, Parkinson disease, stroke, and attention deficit-hyperactivity disorder are reviewed.Conclusions-There are several conditions where the evidence for mind-body therapies is quite strong such as migraine headache. Mind-body therapies for other neurology applications have limited evidence due mostly to small clinical trials and inadequate control groups.

show abstract

Section: Placebo Effectsmentioning

confidence: 99%

Mind–body interventions

Wahbeh

Elsas

Oken³

2008

Neurology

282

127

View full text Add to dashboard Cite

show abstract

“…Some complementary and alternative therapies, including acupuncture, 97 trigger point injections, 98 manual treatment including chiropractic 99 and massage 100 therapies, hypnotherapy, 90 biofeedback, 101 tai-chi, 102 and yoga, 103 may be effective treatments for some patients with fibromyalgia. Dr. Goldenberg stressed that the evidence is tentative and more research is needed.…”

Section: Other Nonpharmacologic Therapiesmentioning

confidence: 99%

Understanding Fibromyalgia and Its Related Disorders

Goldenberg¹

2008

Prim. Care Companion J. Clin. Psychiatry

View full text Add to dashboard Cite

“…Since relaxation training alone has a beneficial effect in the treatment of chronic pain and is recommended for treatment of FM [37][38][39][40], it remains unclear if the positive effects on pain were due to EMG-BFB. Only in 1 study of the meta-analysis the patients learned to relax their muscles according to visual and audio feedback without additional relaxation strategies [41]. That study described a significant reduction of pain measured by a visual analog scale (VAS), but found no group difference for the FIQ.…”

Section: Discussionmentioning

confidence: 99%

Electromyogram Biofeedback in Patients with Fibromyalgia: A Randomized Controlled Trial

et al. 2017

View full text Add to dashboard Cite

Background/Aim: Electromyogram (EMG) biofeedback is used in chronic pain but its effectiveness in patients with fibromyalgia is unclear. The objective of this randomized controlled clinical trial was to evaluate the effectiveness of EMG biofeedback in patients with fibromyalgia. Methods: Patients were recruited from a waiting list at the fibromyalgia day care clinic at the University Hospital Munich. The study intervention comprised 14 sessions of EMG biofeedback during 8 weeks in addition to the usual care. The control intervention was usual care alone. Assessments were scheduled before intervention (T0), after intervention (T1), and 3 months after the end of intervention (T2). The primary outcome measure was the Fibromyalgia Impact Questionnaire (FIQ). Secondary outcome measures included additional patient-oriented measures and the pressure-pain threshold in the trapezius muscles. Effectiveness was analyzed by significance tests and standardized effect sizes (ES). Results: 36 patients completed the study. EMG biofeedback did not improve the health status (FIQ, T1: p = 0.95, ES = 0.02; T2: p = 0.52, ES = 0.26). Among the secondary outcome measures, only the pressure-pain threshold at the trapezius muscles showed an improvement in the intervention group (T1: p = 0.016, ES = 0.84). Conclusion: EMG biofeedback showed no health status improvement in patients with fibromyalgia.

show abstract

Management of patients with fibromyalgia using biofeedback: A randomized control trial

Cited by 34 publications

References 12 publications

Mind–body interventions

Mind–body interventions

Understanding Fibromyalgia and Its Related Disorders

Electromyogram Biofeedback in Patients with Fibromyalgia: A Randomized Controlled Trial

Contact Info

Product

Resources

About